Noticias Inhibrx Biosciences Inc - INBX | Acciones NASDAQ | ADVFN

US Dollar vs MXN

Regístrate para obtener gráficos en tiempo real, herramientas de análisis y precios.

Regístrate

Inhibrx Biosciences Inc (INBX)

13.49

-0.05

(-0.37%)

Cerrado 17 Enero 3:00PM

Delayed by 15 minutes

12.90

-0.59

( -4.37% )

Pre Mercado: 6:02AM

Delayed by 15 minutes

Herramientas de nivel profesional para inversores individuales.

Form 8-K - Current report

Inhibrx Inc. Stockholders Approve Sale of INBRX-101 to Sanofi

Inhibrx Inc. Stockholders Approve Sale of INBRX-101 to Sanofi PR Newswire SAN DIEGO, May 24, 2024 SAN DIEGO...

Form 144 - Report of proposed sale of securities

Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material

Form 8-K - Current report

Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material

Inhibrx, Inc. Announces Updated When-Issued Trading Date for Anticipated Spin-Off

Inhibrx, Inc. Announces Updated When-Issued Trading Date for Anticipated Spin-Off PR Newswire SAN DIEGO, May...

Form 8-K - Current report

Form 4 - Statement of changes in beneficial ownership of securities

Form 8-K - Current report

Inhibrx, Inc. Announces Record Date and Expected Distribution Time for Anticipated Spin-Off and the Expected Merger Effective Time for Anticipated Merger

Inhibrx, Inc. Announces Record Date and Expected Distribution Time for Anticipated Spin-Off and the Expected...

Form 144 - Report of proposed sale of securities

Form 144 - Report of proposed sale of securities

Form 144 - Report of proposed sale of securities

Form 144 - Report of proposed sale of securities

1
2
Próximo

Monksdream

Monksdream 3 meses hace

Monksdream

Monksdream 4 meses hace

Monksdream

Monksdream 4 meses hace

Monksdream

Monksdream 10 meses hace

TrendTrade2016

TrendTrade2016 2 años hace

heres the dolla...boom!!

TrendTrade2016

TrendTrade2016 2 años hace

INBX DOLLA RUMMER IN PROCESS

TrendTrade2016

TrendTrade2016 2 años hace

INBX...PRE MARKET VOL

Jaydixson1

Jaydixson1 2 años hace

Seems to be dropping

make it happen

make it happen 2 años hace

Numbers do not make sense. They need to raise so much to keep the Phases going. So much debt and money burn with worse quarters and barley any revs. Not bashing it's just what it is. 1,000's of percent's negative on profit. Revenue $0.18 Book Value -$0.12. Also imo this volume isn't sustainable 9 times normal as of now

Profitability
Profit Margin 0.00%
Operating Margin -1,448.76%

Management Effectiveness
Return on Assets -37.98%
Return on Equity -562.25%

Income Statement
Revenue 7.03M
Revenue Per Share 0.18
Quarterly Revenue Growth (yoy) -25.50%
Gross Profit -64.21M
EBITDA -100.6M
Net Income Avi to Common -110.75M
Diluted EPS -2.44

Balance Sheet
Total Debt 175.7M
Book Value Per Share -0.13

Cash Flow Statement
Operating Cash Flow -90.16M
Levered Free Cash Flow -46.31M

Inhibrx Biosciences

Delayed Upgrade Clock

Soporte: (55) 4170 8128 | soporte@advfn.mx

Al acceder a los servicios disponibles de ADVFN usted acepta quedar sujerto a los Términos y Condiciones